District hospitals in snakebite-endemic regions frequently decide whether to refer a patient to a tertiary centre before antivenom availability is confirmed, and the resulting referral timing error is a function of both clinical uncertainty and stock-record uncertainty. the present analysis formalises that decision as a constrained triage problem in which the triage policy observes a noisy antivenom stock signal and must choose between holding the patient and referring immediately. A constraint-aware triage model is developed that separates clinical severity estimation from stock-record reliability, and a formal analysis establishes conditions under which the optimal referral threshold shifts as a function of record reliability. The model is evaluated through a replication-based design characterisation of the before-after-control-impact estimator under a declared variance structure (between-cluster SD = 6.0, residual SD = 4.5, intraclass correlation = 0.64), with power estimated across 2000 design cells. The analysis indicates that 54 clusters are required to detect a 5 percentage-point effect at 80% power, and that the minimum detectable effect at 80% power declines as cluster count increases from 8 to 32. The contribution is a formal statement of how stock-record unreliability propagates into referral-timing error, and a demonstration that triage thresholds calibrated on clinical severity alone are systematically miscalibrated when stock records are noisy.
No takes yet. Share an insight, caveat, or question.
Ouédraogo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: